Loading
Latest filing published 31 Mar 2026 for Evonik Industries AG, €59k. Read the official filing
Based on 6 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Dr. Claudine Mollenkopf appears in our data through filings on Evonik Industries AG shares, published by BaFin. The record holds 7 filings, for trades running from 2 June 2025 to 30 March 2026.
No open-market sale appears; the market trades are 7 purchases worth €612k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2026, the count stands at 2 purchases and no sales.
A typical purchase (the median) is worth €95k. Clusters matter here: 3 out of 6 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. After 6 purchases with a full 90-day history, the hit rate stands at 17% and the median 90-day move at -8.2%. This is a record of the past, not a forecast.
The latest filing, published on 31 March 2026, reports an open-market purchase of €59k in Evonik Industries AG. Typically, a trade is published a median of 1 day after it takes place. For comparison, MAR article 19 gives managers three business days to notify a trade. Every figure here comes from the filings published by BaFin and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations